Cannabis Science Releases its 2017 Guidance Report for 2nd Quarter 2017, and Outlines Company’s Performance and Growth Opportunities as the Medical Cannabis Industry Expands Dramatically

IRVINE, CA–(Marketwired – Jul 5, 2017) – Cannabis Science, Inc. ( OTC PINK : CBIS ), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce that the Company has already achieved a good number of its goals for 2017. The Growth Guidance Report has…